Aspacytarabine

In this video, Richard M. Stone, MD, professor of medicine at Harvard Medical School and director, translation research, adult leukemia program at Dana Farber Institute, spoke with Healio about a study presented at ASCO 2021 that showed high doses of aspacytarabine are safe to use in older patients with acute myeloid leukemia.

The novel antimetabolite aspacytarabine appeared safe and efficacious as first-line therapy for patients with acute myeloid leukemia unfit for intensive chemotherapy, according to a study presented during the virtual ASCO Annual Meeting.